[1]苏奋翔,张艳霞,安方玉,等.林氏降脂方对高脂血症大鼠肾脏的影响[J].西部中医药,2016,29(04):22-25.
　SU Fenxiang,ZHANG Yanxia,AN Fangyu,et al.Effects of LinShiJiangZhi Prescription on the Kidney of the Rats with Hyperlipoidemia[J].Western Journal of Traditional Chinese Medicine,2016,29(04):22-25.
点击复制

林氏降脂方对高脂血症大鼠肾脏的影响()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
29
期数:
2016年04期
页码:
22-25
栏目:
出版日期:
2016-04-15

文章信息/Info

Title:
Effects of LinShiJiangZhi Prescription on the Kidney of the Rats with Hyperlipoidemia
文章编号:
1004-6852(2016)04-0022-04
作者:
苏奋翔1，张艳霞2，安方玉2，李明淑1，陈绍仪3，舒畅2
1 甘肃省中医院白银分院，甘肃 白银 730900； 2 甘肃中医药大学； 3 白银市第二人民医院
Author(s):
SU Fenxiang1, ZHANG Yanxia2, AN Fangyu2, LI Mingshu1, CHEN Shaoyi3, SHU Chang2
1 Baiyin Branch of Gansu Provincial Hospital of Traditional Chinese Medicine, Baiyin 730090, China;2 Gansu University of Traditional Chinese Medicine; 3 The Second People′s Hospital of Baiyin City
关键词:
高脂血症; 林氏降脂方; 血脂; 大鼠; 肾脏
Keywords:
hyperlipoidemia;  LinShiJiangZhi prescription;  blood lipid;  rats;  the kidney
分类号:
R285.5
摘要:
目的：观察林氏降脂方对高脂血症大鼠肾脏的影响。方法：将60只雄性SD大鼠，随机分为正常对照组、模型组、脂脉康胶囊组、林氏降脂方高(1.2962 g/mL)、中(0.6481 g/mL)、低(0.3241 g/mL)剂量组，每组10只。正常对照组普通饲料喂养，其余各组高脂乳剂联合高脂饲料喂养建立高脂血症模型并按实验方案给药，6周后，处死各组大鼠，分离血清，测总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)并取肾脏，称重，计算肾脏指数后，切片，HE染色。结果：与正常组相比，模型组TC、TG、LDL-C均显著升高，差异有统计学意义(P＜0.05)，HDL-C显著降低，差异有统计学意义(P＜0.05)；脂脉康胶囊组HDL-C无明显变化，差异无统计学意义(P＞0.05)。与模型组相比较，脂脉康胶囊组及林氏降脂方高剂量组TC、TG、LDL均明显降低，差异有统计学意义(P＜0.05)，HDL-C明显升高，差异有统计学意义(P＜0.05)。病理切片显示，林氏降脂方能改善高脂血症大鼠肾脏瘀血。结论：林氏降脂方可改善高脂血症大鼠肾脏的病变。
Abstract:
Objective: To observe the influence of LinShiJiangZhi prescription on the kidney of the rats with hyperlipoidemia. Methods: Sixty rats were randomized into normal control group, the model group, ZhiMaiKang capsules group, high (1.2962 g/mL), moderate (0.6481 g/mL) and low (0.3241 g/mL) doses groups of LinShiJiangZhi prescription randomly, ten rats each group. The rats in normal control group were fed with ordinary fodder, other groups were fed with high fat emulsion combined with high fat fodder to establish the model with hyperlipoidemia, they were medicated according to experimental plan and sacrificed in six weeks, the levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein-cholesterol(LDL-C) and high density lipoprotein-cholesterol (HDL-C) were detected after the serum was separated, the kidney was taken out and weighed to calculate kidney index, and sliced after HE staining. Results: Compared with the control group, the levels of TC, TG, LDL-C of the model group raised evidently (P＜0.05), the levels of HDL-C decreased clearly, and the difference had statistical meaning(P＜0.05); TG and HDL-C changed indistinctly in ZhiMaiKang capsules group, and the difference had no statistical meaning(P＞0.05). Compared with the model group, the levels of TC, TG and LDL in ZhiMaiKang capsules group and high doses group of LinShiJiangZhi prescription decreased obviously(P＜0.05), HDL-C raised obviously, and the difference showed statistical meaning(P＜0.05). The results of pathological slices showed that LinShiJiangZhi prescription could improve blood stasis in the kidney of the rats with hyperlipoidemia. Conclusion: LinShiJiangZhi prescription could improve renal pathology of the rats with hyperlipoidemia.

相似文献/References:

[1]杨健,张红武△,杨如意.活血化浊胶囊治疗高脂血症的实验研究[J].西部中医药,2012,25(08):17.
　YANG Jian,ZHANG Hong-wu,YANG Ru-yi.Experimental Study on HuoXue HuaZhuo Capsule in Treating Hyperlipidemia[J].Western Journal of Traditional Chinese Medicine,2012,25(04):17.
[2]高艳琼,延华,金瑞瑞.泽泻汤治疗高脂血症的临床疗效观察[J].西部中医药,2015,28(09):88.
[3]高世东.从肝脾肾论治高脂血症[J].西部中医药,2013,26(06):18.
　GAO Shidong.On Hyperlipoidemia Treated from Liver, Spleen and Kidney[J].Western Journal of Traditional Chinese Medicine,2013,26(04):18.
[4]袁帆,张全华,冉子伯.降脂类中药组方治疗高脂血症临床观察[J].西部中医药,2014,27(05):85.
　YUAN Fan,ZHANG Quanhua,RAN Zibo.Clinical Observation on Lipid-lowering Herbs and Prescriptions in the Treatment for Hyperlipidemia[J].Western Journal of Traditional Chinese Medicine,2014,27(04):85.
[5]滕云.七味消脂饮治疗高脂血症临床观察[J].西部中医药,2013,26(05):77.
　TENG Yun.Clinical Observation on QiWei XiaoZhiYin in Treating Hyperlipoidemia[J].Western Journal of Traditional Chinese Medicine,2013,26(04):77.
[6]张和平,谈建新,王敬敏,等.心脑通配方对大鼠颈总动脉粥样硬化斑块中MMP-2的影响[J].西部中医药,2014,27(03):32.
　ZHANG Heping,TAN Jianxin,WANG Jingmin,et al.Effects of XinNaoTong Prescription on MMP-2 in Carotid Atherosclerotic Plaque of Rats[J].Western Journal of Traditional Chinese Medicine,2014,27(04):32.
[7]李龑,杨舒淳,吴芳,等.化脂丸对高脂血症患者血脂的影响*[J].西部中医药,2014,27(04):31.
　LI Yan,YANG Shuchun,WU Fang,et al.Effects of HuaZhi Pill on Blood Lipid of the Patients with Hyperlipemia[J].Western Journal of Traditional Chinese Medicine,2014,27(04):31.
[8]李淑玲,刘凯△.李应东教授从脾气虚论治高脂血症[J].西部中医药,2017,30(03):53.
　LI Shuling,LIU Kai.Professor LI Yingdong′s Treatment for Hyperlipidemia from Spleen-Qi Deficiency[J].Western Journal of Traditional Chinese Medicine,2017,30(04):53.
[9]陈薇薇,苏晓△,唐华燕,等.舒肝祛脂胶囊治疗高脂血症30例[J].西部中医药,2018,31(06):82.
　CHEN Weiwei,SU Xiao,TANG Huayan,et al.Treating 30 Cases of Hyperlipemia by Liver-soothing Fat-eliminating Capsules[J].Western Journal of Traditional Chinese Medicine,2018,31(04):82.
[10]刘育苗,杨晓强△.脂必泰联合阿托伐他汀钙对冠心病患者血脂的影响[J].西部中医药,2018,31(12):89.
　LIU Yumiao,YANG Xiaoqiang.The Effects of ZhiBiTai Capsules and Atorvastatin Calcium on Blood Lipid of CHD Patients[J].Western Journal of Traditional Chinese Medicine,2018,31(04):89.
[11]苏奋翔,张艳霞,安方玉,等.林氏降脂方对高脂血症大鼠血脂和血液流变学的影响[J].西部中医药,2015,28(10):12.

备注/Memo

备注/Memo:
收稿日期：2015-12-27*基金项目：甘肃省中医药管理局科研项目(编号GZK-2013-70)。作者简介：苏奋翔(1963—)，男，副主任医师。研究方向：脾胃病的临床诊治。
更新日期/Last Update: 2016-04-15